About: Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract
Creator	Burgos-Díaz, César Bustamante, Mariela Oliveira, Wanderley Oomah, & Rubilar, Mónica Shene, Carolina
topic	covid:db139f1bc96dc1b72ab2ec3b3eaff1510a1e9368#this
Source	Medline; PMC
abstract	The prebiotics and probiotics market is constantly growing due to the positive effects of its consumption on human health, which extends beyond the digestive system. In addition, the synbiotic products market is also expanding due to the synergistic effects between pre- and probiotics that provide additional benefits to consumers. Pre- and probiotics are being evaluated for their effectiveness to treat and prevent infectious diseases in other parts of the human body where microbial communities exist. This review examines the scientific data related to the effects of pre- and probiotics on the treatment of diseases occurring in the skin, female urogenital tract, and respiratory tract. The evidence suggests that probiotics consumption can decrease the presence of eczema in children when their mothers have consumed probiotics during pregnancy and lactation. In women, probiotics consumption can effectively prevent recurrent urinary tract infections. The consumption of synbiotic products can reduce respiratory tract infections and their duration and severity. However, the outcomes of the meta-analyses are still limited and not sufficiently conclusive to support the use of probiotics to treat infectious diseases. This is largely a result of the limited number of studies, lack of standardization of the studies, and inconsistencies between the reported results. Therefore, it is advisable that future studies consider these shortcomings and include the evaluation of the combined use of pre- and probiotics.
has issue date	2019-11-26(xsd:dateTime)
bibo:doi	10.1007/s12223-019-00759-3
bibo:pmid	31773556
has license	no-cc
sha1sum (hex)	db139f1bc96dc1b72ab2ec3b3eaff1510a1e9368
schema:url	https://doi.org/10.1007/s12223-019-00759-3
resource representing a document's title	Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract
has PubMed Central identifier	PMC7090755
has PubMed identifier	31773556
schema:publication	Folia Microbiol (Praha)
resource representing a document's body	covid:db139f1bc96dc1b72ab2ec3b3eaff1510a1e9368#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/db139f1bc96dc1b72ab2ec3b3eaff1510a1e9368
is schema:about of	named entity 'positive' named entity 'synergistic effects' named entity 'standardization' named entity 'skin' named entity 'urogenital tract' covid:arg/db139f1bc96dc1b72ab2ec3b3eaff1510a1e9368 named entity 'probiotics' named entity 'prevent' named entity 'support' named entity 'probiotics' named entity 'infectious diseases' named entity 'probiotics' named entity 'duration' named entity 'eczema' named entity 'probiotics' named entity 'number' named entity 'However' named entity 'digestive system' named entity 'respiratory tract infections' named entity 'probiotics' named entity 'synbiotic' named entity 'human body' named entity 'probiotics' named entity 'eczema' named entity 'urogenital tract' named entity 'infectious diseases' named entity 'microbial' named entity 'human health' named entity 'prebiotics' named entity 'probiotics' named entity 'prebiotics' named entity 'Probiotics' named entity 'urogenital tract' named entity 'probiotics' named entity 'skin lesions' named entity 'probiotics' named entity 'Acne vulgaris' named entity 'prebiotics' named entity 'lactobacilli' named entity 'acne' named entity 'antibiotic' named entity 'URT' named entity 'follow-up' named entity 'Preterm infants' named entity 'pathogenic bacteria' named entity '8 days' named entity 'capsules' named entity 'Lactobacillus johnsonii' named entity 'serum' named entity 'metabolic activity' named entity 'prophylactic' named entity 'Lactobacilli' named entity 'fat-free' named entity 'adenovirus' named entity 'UTIs' named entity 'asthma' named entity 'L. plantarum' named entity 'oligosaccharide' named entity 'probiotic' named entity 'probiotic' named entity 'L. casei' named entity 'double-blind' named entity 'glucomannan' named entity 'anti-inflammatory' named entity 'meta-analysis' named entity 'prenatal' named entity 'lactobacilli' named entity '12 weeks' named entity 'probiotics' named entity 'ureters' named entity 'organ' named entity 'probiotic' named entity 'urogenital tract' named entity 'probiotic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software